Cost Savings Associated with Expanded Hospice Use in Medicare

Journal of Palliative Medicine

Volumn 18, Issue 5, 2015, Pages 400-401

  Powers, Brian W ^a   Makar, Maggie ^b   Jain, Sachin H ^a   Cutler, David M ^c,d   Obermeyer, Ziad ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER PROGNOSIS; COST CONTROL; HOSPICE; HUMAN; LENGTH OF STAY; LETTER; MEDICARE; NORMAL HUMAN; PHYSICIAN; PRACTICE GUIDELINE; ECONOMICS; HOSPICE CARE; MORTALITY; NEOPLASM; PATHOLOGY; PROCEDURES; PROGNOSIS; STATISTICS AND NUMERICAL DATA; TERMINALLY ILL PATIENT; TRENDS; UNITED STATES;

COST SAVINGS; HOSPICE CARE; HUMANS; LENGTH OF STAY; MEDICARE; NEOPLASMS; PROGNOSIS; TERMINALLY ILL; UNITED STATES;

EID: 84929990557     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2015.0014     Document Type: Letter

References (4)

1. Obermeyer Z, Makar M, Abujaber S, et al.: Association between the Medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer. JAMA 2014;312:1888-1896.
2. Steinhauser KE, Christakis NA, Clipp EC, et al.: Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 2000;284:2476-2482.
3. Glare P, Christakis NA: Prognosis in Advanced Cancer. Oxford: Oxford University Press, 2008.
4. Gill TM, Gahbauer EA, Han L, Allore HG: Trajectories of disability in the last year of life. N Engl J Med 2010;362: 1173-1180.